Description
An irreversible EGFR, HER2, and HER4 inhibitor (IC50s = 0.5, 3, and 0.8 nM, respectively); selective for EGFR, HER2, and HER4 over a panel of 23 additional kinases (IC50s = >10 µM); inhibits EGFRT790M/L858R (IC50 = 12 nM in a cell-free assay); decreases EGFR, ERK1/2, and Akt phosphorylation in Calu-3, A549, and SKOV3 cancer cells from 0.001-1 µM; inhibits proliferation of various cancer cells (IC50s = 0.23-16 µM); reduces tumor growth in Calu-3, A549, SKOV3, and HO8910 mouse xenograft models at 25, 50, and 100 mg/kg per day
Formal name: N-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-propenamide, 4-methylbenzenesulfonate
Synonyms: Allitinib
Molecular weight: 621.1
CAS: 1050500-29-2
Purity: ≥98%
Formulation: A crystalline solid